Publication | Closed Access

Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet’s disease

InflammationCytokineAutoimmune DiseaseInterleukin-1 Receptor AntagonistImmunologyPathologyChronic InflammationBehçet ’Immune-mediated Inflammatory DiseasesDisease BiologyCytokine InhibitorsMedicineInflammatory DiseaseImmune Dysregulation